{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:56:26Z","timestamp":1789844186816,"version":"4.0.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["F31HL175979"],"award-info":[{"award-number":["F31HL175979"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["F31HL170972"],"award-info":[{"award-number":["F31HL170972"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL174521"],"award-info":[{"award-number":["R01HL174521"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA058933"],"award-info":[{"award-number":["R01DA058933"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["25PRE1374495"],"award-info":[{"award-number":["25PRE1374495"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015087","name":"Markey Cancer Center, University of Kentucky","doi-asserted-by":"publisher","award":["P30CA177558"],"award-info":[{"award-number":["P30CA177558"]}],"id":[{"id":"10.13039\/100015087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015087","name":"Markey Cancer Center, University of Kentucky","doi-asserted-by":"publisher","award":["SCR_026405"],"award-info":[{"award-number":["SCR_026405"]}],"id":[{"id":"10.13039\/100015087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007472","name":"University of Kentucky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007472","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jbc.2026.111379","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:19:27Z","timestamp":1773825567000},"page":"111379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Kinase signaling in liver disease via clinical-trial-on-a-PamChip: A distinctive methodology for drug mechanisms and personalized medicine"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7344-7469","authenticated-orcid":false,"given":"Zachary A.","family":"Kipp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn A.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4593-7708","authenticated-orcid":false,"given":"Genesee J.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-Hsin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7365-7172","authenticated-orcid":false,"given":"Sally N.","family":"Pauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7599-1529","authenticated-orcid":false,"suffix":"Jr.","given":"Terry D.","family":"Hinds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.111379_bib1","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1002\/mco2.261","article-title":"Protein posttranslational modifications in health and diseases: functions, regulatory mechanisms, and therapeutic implications","volume":"4","author":"Zhong","year":"2023","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.jbc.2026.111379_bib2","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/hep.32467","article-title":"Hepatic kinome atlas: an in-depth identification of kinase pathways in liver fibrosis of humans and rodents","volume":"76","author":"Creeden","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jbc.2026.111379_bib3","doi-asserted-by":"crossref","first-page":"8679","DOI":"10.3390\/ijms21228679","article-title":"Kinome array profiling of patient-derived pancreatic ductal adenocarcinoma identifies differentially active protein tyrosine kinases","volume":"21","author":"Creeden","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111379_bib4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/biom13020252","article-title":"Suppressing hepatic UGT1A1 increases Plasma Bilirubin, lowers Plasma Urobilin, reorganizes kinase signaling pathways and lipid species and improves fatty liver disease","volume":"13","author":"Bates","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jbc.2026.111379_bib5","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.111379_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/CS20242825","article-title":"Heme oxygenase, biliverdin reductase, and bilirubin pathways regulate oxidative stress and insulin resistance: a focus on diabetes and therapeutics","volume":"139","author":"Lee","year":"2025","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.jbc.2026.111379_bib7","doi-asserted-by":"crossref","first-page":"42911","DOI":"10.1074\/jbc.M111.311662","article-title":"Protein phosphatase 5 mediates lipid metabolism through reciprocal control of glucocorticoid receptor and peroxisome proliferator-activated receptor-gamma (PPARgamma)","volume":"286","author":"Hinds","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111379_bib8","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1016\/j.biocel.2007.08.010","article-title":"Protein phosphatase 5","volume":"40","author":"Hinds","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111379_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3892\/or.2023.8485","article-title":"Roles of protein tyrosine phosphatases in hepatocellular carcinoma progression (Review)","volume":"49","author":"Chen","year":"2023","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jbc.2026.111379_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202139","article-title":"Kinomics toolbox-A web platform for analysis and viewing of kinomic peptide array data","volume":"13","author":"Dussaq","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111379_bib11","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1093\/bioinformatics\/btz858","article-title":"PamgeneAnalyzeR: open and reproducible pipeline for kinase profiling","volume":"36","author":"Bekkar","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jbc.2026.111379_bib12","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1074\/jbc.RA120.013700","article-title":"Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator-activated receptor alpha","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111379_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108363","article-title":"Steroid receptors and coregulators: dissemination of sex differences and emerging technologies","author":"Pauss","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111379_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.matbio.2013.12.002","article-title":"Discoidin domain receptors in disease","volume":"34","author":"Borza","year":"2014","journal-title":"Matrix Biol."},{"key":"10.1016\/j.jbc.2026.111379_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115165","article-title":"The adiponectin-PPARgamma axis in hepatic stellate cells regulates liver fibrosis","volume":"44","author":"Zhao","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2026.111379_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.102010","article-title":"Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation","volume":"88","author":"Muturi","year":"2024","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jbc.2026.111379_bib17","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202402169R","article-title":"Insulin receptor responsiveness governs TGFbeta-induced hepatic stellate cell activation: insulin resistance instigates liver fibrosis","volume":"39","author":"Lee","year":"2025","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2026.111379_bib18","first-page":"1","article-title":"Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification","volume":"149","author":"Chidambaranathan-Reghupaty","year":"2021","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.jbc.2026.111379_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41572-024-00500-6","article-title":"Author correction: hepatocellular carcinoma","volume":"10","author":"Llovet","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jbc.2026.111379_bib20","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.931856","article-title":"Overall survival in patients with hepatocellular carcinoma treated with sorafenib: a Polish experience","volume":"27","author":"Stras","year":"2021","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.jbc.2026.111379_bib21","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3390\/antiox14111326","article-title":"Bilirubin hepatic and intestinal transport and catabolism: physiology, pathophysiology, and benefits","volume":"14","author":"Kipp","year":"2025","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jbc.2026.111379_bib22","article-title":"Bilirubin bioconversion to urobilin in the gut-liver-kidney axis: a biomarker for insulin resistance in the cardiovascular-kidney-metabolic (CKM) syndrome","volume":"163","author":"Kipp","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.jbc.2026.111379_bib23","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1042\/CS20257571","article-title":"The physiology of MASLD: molecular pathways between liver and adipose tissues","volume":"139","author":"Lee","year":"2025","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.jbc.2026.111379_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155607","article-title":"Hepatic insulin receptor: new views on the mechanisms of liver disease","volume":"145","author":"Lee","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.jbc.2026.111379_bib25","article-title":"Hepatocellular carcinoma in 2021: an exhaustive update","volume":"13","author":"Philips","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jbc.2026.111379_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jbc.2026.111379_bib27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.21037\/hbsn-2021-7","article-title":"Combination therapy for advanced hepatocellular carcinoma: do we see the light at the end of the tunnel?","volume":"10","author":"Zhang","year":"2021","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"10.1016\/j.jbc.2026.111379_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.184396","article-title":"Knockdown of ketohexokinase versus inhibition of its kinase activity exert divergent effects on fructose metabolism","volume":"9","author":"Park","year":"2024","journal-title":"JCI Insight."},{"key":"10.1016\/j.jbc.2026.111379_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.105691","article-title":"FOXS1 is increased in liver fibrosis and regulates TGFbeta responsiveness and proliferation pathways in human hepatic stellate cells","volume":"300","author":"Bates","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111379_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101815","article-title":"Loss of carnitine palmitoyltransferase 1a reduces docosahexaenoic acid-containing phospholipids and drives sexually dimorphic liver disease in mice","volume":"78","author":"Zelows","year":"2023","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jbc.2026.111379_bib31","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1152\/ajpregu.00057.2023","article-title":"Loss of hepatic PPARalpha in mice causes hypertension and cardiovascular disease","volume":"325","author":"Badmus","year":"2023","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.jbc.2026.111379_bib32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/med.21455","article-title":"Glypican-3: a promising biomarker for hepatocellular carcinoma diagnosis and treatment","volume":"38","author":"Zhou","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jbc.2026.111379_bib33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.gastro.2020.03.013","article-title":"ABL1, overexpressed in hepatocellular carcinomas, regulates expression of NOTCH1 and promotes development of liver tumors in mice","volume":"159","author":"Wang","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbc.2026.111379_bib34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/FTD.0000000000000440","article-title":"Women administered standard dose imatinib for chronic myeloid leukemia have higher dose-adjusted plasma imatinib and norimatinib concentrations than men","volume":"39","author":"Belsey","year":"2017","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jbc.2026.111379_bib35","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/ejh.12597","article-title":"Gender and BCR-ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia","volume":"96","author":"Lin","year":"2016","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.jbc.2026.111379_bib36","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/282615a0","article-title":"Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line","volume":"282","author":"Aden","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111379_bib37","first-page":"385","article-title":"Establishment and some biological characteristics of human hepatoma cell lines","volume":"66","author":"Dor","year":"1975","journal-title":"Gan"},{"key":"10.1016\/j.jbc.2026.111379_bib38","first-page":"178","article-title":"Production of HBs-antigen by two new human hepatoma cell lines and its enhancement by dexamethasone","volume":"72","author":"Huh","year":"1981","journal-title":"Gan"},{"key":"10.1016\/j.jbc.2026.111379_bib39","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111379_bib40","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.jbc.2026.111379_bib41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.jbc.2026.111379_bib42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.gpb.2018.07.003","article-title":"HCCDB: a database of hepatocellular carcinoma expression Atlas","volume":"16","author":"Lian","year":"2018","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.jbc.2026.111379_bib43","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111379_bib44","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1038\/sj.onc.1205724","article-title":"Phosphatidylinositol-3 kinase inhibitors enhance the anti-leukemia effect of STI571","volume":"21","author":"Klejman","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.111379_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1241056","article-title":"Abl kinases can function as suppressors of tumor progression and metastasis","volume":"13","author":"Marchal","year":"2023","journal-title":"Front Oncol."},{"key":"10.1016\/j.jbc.2026.111379_bib46","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.1182\/blood-2011-01-332783","article-title":"Antileukemic effects of AMPK activators on BCR-ABL-expressing cells","volume":"118","author":"Vakana","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111379_bib47","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/leu.2009.300","article-title":"ON012380, a putative BCR-ABL kinase inhibitor with a unique mechanism of action in imatinib-resistant cells","volume":"24","author":"Wu","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.jbc.2026.111379_bib48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12902-018-0303-x","article-title":"Effect of imatinib on plasma glucose concentration in subjects with chronic myeloid leukemia and gastrointestinal stromal tumor","volume":"18","author":"G\u00f3mez-S\u00e1mano","year":"2018","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.jbc.2026.111379_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167349","article-title":"Imatinib can act as an allosteric activator of Abl kinase","volume":"434","author":"Xie","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jbc.2026.111379_bib50","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-biochem-060713-035524","article-title":"Hierarchy of RNA functional dynamics","volume":"83","author":"Mustoe","year":"2014","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jbc.2026.111379_bib51","doi-asserted-by":"crossref","first-page":"970","DOI":"10.18632\/oncotarget.28257","article-title":"Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors","volume":"13","author":"Tahiri","year":"2022","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.111379_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063723","article-title":"Hypoxic tumor kinase signaling mediated by STAT5A in development of castration-resistant prostate cancer","volume":"8","author":"Roe","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111379_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001607","article-title":"Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer","volume":"8","author":"Hurkmans","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jbc.2026.111379_bib54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/metabo13020215","article-title":"Bilirubin nanoparticle treatment in Obese mice inhibits hepatic ceramide production and remodels liver fat content","volume":"13","author":"Kipp","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.jbc.2026.111379_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2019.108072","article-title":"CRISPR Cas9-mediated deletion of biliverdin reductase A (BVRA) in mouse liver cells induces oxidative stress and lipid accumulation","volume":"672","author":"Gordon","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jbc.2026.111379_bib56","first-page":"35","article-title":"A novel fluorescence-based assay for the measurement of Biliverdin reductase activity","volume":"5","author":"Adeosun","year":"2018","journal-title":"React Oxyg Species (Apex)"},{"key":"10.1016\/j.jbc.2026.111379_bib57","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.trre.2018.06.003","article-title":"Bilirubin, a new therapeutic for kidney transplant?","volume":"32","author":"Sundararaghavan","year":"2018","journal-title":"Transpl. Rev (Orlando)"},{"key":"10.1016\/j.jbc.2026.111379_bib58","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/antiox12010170","article-title":"Bilirubin levels are negatively correlated with adiposity in Obese men and women, and its catabolized product, Urobilin, is positively associated with insulin resistance","volume":"12","author":"Kipp","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jbc.2026.111379_bib59","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.1152\/ajpendo.00405.2020","article-title":"Bilirubin as a metabolic hormone: the physiological relevance of low levels","volume":"320","author":"Creeden","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2026.111379_bib60","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.18632\/oncotarget.12277","article-title":"Glucuronidation and UGT isozymes in bladder: new targets for the treatment of uroepithelial carcinomas?","volume":"8","author":"Sundararaghavan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.111379_bib61","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1021\/acsnano.3c06107","article-title":"Antioxidative hyaluronic acid-bilirubin nanomedicine targeting activated hepatic stellate cells for anti-hepatic-fibrosis therapy","volume":"18","author":"Shinn","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jbc.2026.111379_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.102981","article-title":"The impact of rare cancer and early-line treatments on the benefit of comprehensive genome profiling-based precision oncology","volume":"9","author":"Kubo","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.jbc.2026.111379_bib63","first-page":"525","article-title":"Assessment of clinical benefit of integrative genomic profiling in advanced solid tumors","volume":"7","author":"Cobain","year":"2021","journal-title":"JAMA Oncol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826002498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826002498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:34:55Z","timestamp":1779838495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826002498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0021925826002498"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111379","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kinase signaling in liver disease via clinical-trial-on-a-PamChip: A distinctive methodology for drug mechanisms and personalized medicine","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"111379"}}